tag:blogger.com,1999:blog-5143548066694854721.post6909613889910184476..comments2024-02-15T14:15:24.189+08:00Comments on 80後標竿人生: 石藥集團(1093) 2018 全年業績 記錄80後標竿http://www.blogger.com/profile/16484132009656959776noreply@blogger.comBlogger6125tag:blogger.com,1999:blog-5143548066694854721.post-38978609662860413312019-03-20T20:36:34.128+08:002019-03-20T20:36:34.128+08:00不錯, 加油!不錯, 加油!80後標竿https://www.blogger.com/profile/16484132009656959776noreply@blogger.comtag:blogger.com,1999:blog-5143548066694854721.post-88923201271440538322019-03-20T18:57:53.466+08:002019-03-20T18:57:53.466+08:00我選了下游醫藥股
環球醫療(醫院管理)國藥控股(醫藥綜合企業)
慢慢研究石藥和中國生物製藥
藥...我選了下游醫藥股<br /><br />環球醫療(醫院管理)國藥控股(醫藥綜合企業)<br /><br />慢慢研究石藥和中國生物製藥<br /><br />藥明生物特色在於代工Chun yeung akhttps://www.blogger.com/profile/16746029969761317370noreply@blogger.comtag:blogger.com,1999:blog-5143548066694854721.post-77720769251021201192019-03-20T18:39:37.646+08:002019-03-20T18:39:37.646+08:00藥明相比另外 兩支龍頭石藥 中生,藥明股價熱炒回升不少。因此,石藥中生股價更見合理。藥明相比另外 兩支龍頭石藥 中生,藥明股價熱炒回升不少。因此,石藥中生股價更見合理。80後標竿https://www.blogger.com/profile/16484132009656959776noreply@blogger.comtag:blogger.com,1999:blog-5143548066694854721.post-22742421847214507662019-03-20T18:35:19.875+08:002019-03-20T18:35:19.875+08:00Pe 140左右,但盈利增長預期強勁, PEG不貴。因此資金仍然流入。Pe 140左右,但盈利增長預期強勁, PEG不貴。因此資金仍然流入。80後標竿https://www.blogger.com/profile/16484132009656959776noreply@blogger.comtag:blogger.com,1999:blog-5143548066694854721.post-90938074818776132692019-03-20T18:31:42.646+08:002019-03-20T18:31:42.646+08:00藥明2018 純利增150%,可說是增長爆炸性,處高速增長期,PE不便宜了,股價也由45元回升至今一...藥明2018 純利增150%,可說是增長爆炸性,處高速增長期,PE不便宜了,股價也由45元回升至今一倍,熱錢流入不少。<br /><br />藥企中的明星股。80後標竿https://www.blogger.com/profile/16484132009656959776noreply@blogger.comtag:blogger.com,1999:blog-5143548066694854721.post-41683201588603892412019-03-20T18:15:26.572+08:002019-03-20T18:15:26.572+08:00標杆兄,你對藥明生物有什麼看法?標杆兄,你對藥明生物有什麼看法?Chun yeung akhttps://www.blogger.com/profile/16746029969761317370noreply@blogger.com